Article
Immunology
Sonia Kiran, Mousumi Mandal, Ahmed Rakib, Amandeep Bajwa, Udai P. Singh
Summary: This study investigates the role and mechanism of miR-10a-3p in adipose inflammation and adipogenesis using ex vivo and in vitro approaches. The findings suggest that miR-10a-3p mimic reduces the expression of inflammatory cells and cytokines, and induces the expression of FoxP3 in adipose tissue. In vitro experiments also show that miR-10a-3p mimic reduces the expression of inflammatory genes and lipid accumulation. This study provides a new opportunity for the development of miR-10a-3p as a novel therapeutic for adipose inflammation and its associated metabolic disorders.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Pharmacology & Pharmacy
Seung Ki Kim, Geon Kim, Bo-Hyun Choi, Dayoung Ryu, Sae-Kwang Ku, Mi-Kyoung Kwak
Summary: The study identified that sarpogrelate and telmisartan can alleviate nephropathy progression in rats with comorbid hypertension and diabetes, with urinary miRNA miR-199a-3p potentially serving as a marker for nephropathy treatment.
BIOCHEMICAL PHARMACOLOGY
(2021)
Article
Pharmacology & Pharmacy
Xiaodong Gu, Ruiqiang Weng, Jingyuan Hou, Sudong Liu
Summary: In this study, miR-199a-3p was found to suppress endothelial inflammation and adhesion by targeting the mTOR signaling pathway and increasing autophagy. This miRNA plays an important role in the early stages of cardiovascular disease.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2022)
Article
Multidisciplinary Sciences
Omayma O. Abdelaleem, Shereen Rashad Mohammed, Hassan S. El Sayed, Sherin Khamis Hussein, Doaa Y. Ali, Mostafa Y. Abdelwahed, Sylvana N. Gaber, Nada F. Hemeda, Rehab G. Abd El-Hmid
Summary: This study found that serum levels of miR-34a-5p and miR-199a-3p were significantly reduced in neonates with sepsis, and they were associated with the severity of sepsis.
Article
Oncology
Guiqin Hou, Yang Wang, Mengying Zhang, Yi Hu, Yu Zhao, Ang Jia, Peng Wang, Wuduo Zhao, Wen Zhao, Zhaoming Lu
Summary: The dysregulation of microRNA, specifically miR-199a-3p, plays a crucial role in the tumorigenic processes of esophageal squamous cell carcinoma (ESCC). Overexpression of miR-199a-3p inhibits cell proliferation, migration, and invasion, induces cell cycle retardation and apoptosis in ESCC cells. Additionally, miR-199a-3p is shown to modulate the mTOR/p70S6K and PI3K/Akt pathways, providing new insights into the treatment of ESCC.
Article
Medicine, Research & Experimental
Xiaolei Yao, XiaoXiao Gao, Yongjin Bao, M. A. El-Samahy, Jinyu Yang, Zhibo Wang, Xiaodan Li, Guomin Zhang, Yanli Zhang, Wujun Liu, Feng Wang
Summary: The study identified a lncRNA named FDNCR in sheep ovaries that regulates fecundity by binding miR-543-3p and DCN, playing a role in the TGF-beta pathway, and promoting granulosa cell apoptosis.
MOLECULAR THERAPY-NUCLEIC ACIDS
(2021)
Article
Multidisciplinary Sciences
Rongrong Ding, Jianming Zheng, Ning Li, Qi Cheng, Mengqi Zhu, Yanbing Wang, Xinlan Zhou, Zhanqing Zhang, Guangfeng Shi
Summary: DZNep suppresses hepatic fibrosis by regulating the miR-199a-5p/SOCS7 axis, reducing the expression of fibrosis markers. DZNep may represent a novel treatment for fibrosis.
Article
Multidisciplinary Sciences
Fei Lu, Shuran Chen, Weijun Shi, Xu Su, Huazhang Wu, Mulin Liu
Summary: The study found that CRC patients with high GPC1 expression had poor overall survival, and GPC1 may promote proliferation and migration of CRC cells by influencing the TGF-beta 1 signaling pathway. Additionally, silencing GPC1 inhibited TGF-beta 1 levels and increased SMAD2 expression.
Article
Health Care Sciences & Services
Paola Fuso, Mariantonietta Di Salvatore, Concetta Santonocito, Donatella Guarino, Chiara Autilio, Antonino Mule, Damiano Arciuolo, Antonina Rinninella, Flavio Mignone, Matteo Ramundo, Brunella Di Stefano, Armando Orlandi, Ettore Capoluongo, Nicola Nicolotti, Gianluca Franceschini, Alejandro Martin Sanchez, Giampaolo Tortora, Giovanni Scambia, Carlo Barone, Alessandra Cassano
Summary: The up-regulation of miRNAs let-7a-5p, mirR-100-5p, miR-101-3p, and miR-199a-3p is associated with better event-free survival and overall survival in breast cancer patients, regardless of breast cancer subtypes.
JOURNAL OF PERSONALIZED MEDICINE
(2021)
Article
Medicine, Research & Experimental
Ni Zeng, Yu-Qing Huang, Yu-Min Yan, Zhi-Qin Hu, Zhuo Zhang, Jia-Xin Feng, Ji-Shen Guo, Jie-Ning Zhu, Yong-Heng Fu, Xi-Pei Wang, Meng-Zhen Zhang, Jin-Zhu Duan, Xi-Long Zheng, Jin-Dong Xu, Zhi-Xin Shan
Summary: miR-199a-5p and -3p are co-upregulated in the myocardium during cardiac remodeling and can aggravate cardiac hypertrophy and fibrosis by targeting different genes. Inhibition of miR-199a-5p and -3p may present a new therapeutic strategy for cardiac remodeling.
MOLECULAR THERAPY-NUCLEIC ACIDS
(2021)
Article
Cell Biology
Yuhang Li, Qianqian Ren, Xingping Wang, Zhuoma Luoreng, Dawei Wei
Summary: This study revealed that bta-miR-199a-3p inhibits LPS-induced inflammation in bMECs by directly targeting CD2AP and regulating the PI3K/AKT/NF-kappa B signaling pathway.
Article
Cell Biology
Hyunjung Lee, Joon-Seog Kong, Seung-Sook Lee, Areumnuri Kim
Summary: Increased expressions of TGF beta and PODXL in CRC cells following radiation exposure promote cell migration and invasiveness. Silencing PODXL or using a TGF beta-pathway inhibitor can inhibit radiation-induced CRC progression, providing potential therapeutic targets for radiotherapy-resistant CRC patients.
Article
Oncology
Paula Gonzalez-Lopez, Marta Alvarez-Villarreal, Ruben Ruiz-Simon, Andrea R. Lopez-Pastor, Melina Vega de Ceniga, Leticia Esparza, Jose L. Martin-Ventura, Oscar Escribano, Almudena Gomez-Hernandez
Summary: MicroRNAs miR-15a-5p and miR-199a-3p are significantly decreased in aortic and carotid samples from atherosclerosis patients and mice. Overexpression of these miRNAs can reduce inflammation and progression of atherosclerosis. MiR-15a-5p may serve as a novel diagnostic biomarker for advanced atherosclerosis.
CLINICAL AND TRANSLATIONAL MEDICINE
(2023)
Article
Biotechnology & Applied Microbiology
Jiang Zhu, Yuming Luo, Yue Zhao, Yao Kong, Hanhao Zheng, Yuting Li, Bowen Gao, Le Ai, Hao Huang, Jian Huang, Zhihua Li, Changhao Chen
Summary: The study identified a novel circRNA circEHBP1 that promotes lymphangiogenesis and lymphatic metastasis in bladder cancer by regulating the TGF beta R1/VEGF-D pathway, highlighting a potential biomarker and therapeutic target for bladder cancer patients with poor prognosis.
Article
Oncology
Zelin Yang, Liang Yang, Zhenkai Sun, Yuxi Rong, Chenglian Bai, Qiaoxiang Dong, Lin Jian
Summary: APOC1 is overexpressed in glioblastoma and is inversely related to patient prognosis. Overexpression of APOC1 promotes cell proliferation, migration, and invasion, while inhibition of APOC1 reduces tumor growth. miRNA-660-3p suppresses tumorigenesis by targeting APOC1. Therefore, the miRNA-660-3p/APOC1 axis can serve as potential intervention targets in managing glioblastoma progression.
CANCER BIOLOGY & THERAPY
(2023)
Article
Oncology
Fangfang Zhao, Youguang Pu, Liting Qian, Chunbao Zang, Zhenchao Tao, Jin Gao
Article
Oncology
Chunbao Zang, Xujie Liu, Bing Li, Yanqiong He, Shen Jing, Yujia He, Wenli Wu, Bingqian Zhang, Shuhong Ma, Weiwei Dai, Shaolin Li, Zhiping Peng
Article
Multidisciplinary Sciences
Youguang Pu, Fangfang Zhao, Haiyan Wang, Shanbao Cai
SCIENTIFIC REPORTS
(2017)
Article
Oncology
Wang Haiyan, Zhao Fangfang, Cai Shanbao, Pu Youguang
JOURNAL OF BONE ONCOLOGY
(2019)
Article
Medicine, Research & Experimental
Chunbao Zang, Fangfang Zhao, Youguang Pu
BIOMEDICINE & PHARMACOTHERAPY
(2019)
Article
Cell Biology
Dabing Huang, Xianhai Zhu, Yong Wang, Haobin Yu, Youguang Pu
Article
Oncology
Feng Wang, Lingsuo Kong, Youguang Pu, Fengmei Chao, Chunbao Zang, Wei Qin, Fangfang Zhao, Shanbao Cai
Summary: This study identified the role of lncRNA DICER1-AS1 and miR-34a-5p in drug resistance of osteosarcoma cells, revealing their negative correlation and regulation in drug resistance. The findings suggest a new lncRNA-regulated network in osteosarcoma tumorigenesis and propose DICER1-AS1 as a potential biomarker and therapeutic target against osteosarcoma cells.
FRONTIERS IN ONCOLOGY
(2021)
Article
Cell Biology
Youguang Pu, Yiao Tan, Chunbao Zang, Fangfang Zhao, Cifeng Cai, Lingsuo Kong, Hui Deng, Fengmei Chao, Ran Xia, Minghua Xie, Fangfang Ge, Yueyin Pan, Shanbao Cai, Dabing Huang
Summary: LAMTOR5-AS1 globally regulates chemotherapy-induced cellular oxidative stress by controlling the expression and activity of NRF2, inhibiting proliferation and multidrug resistance of osteosarcoma cells.
CELL DEATH & DISEASE
(2021)
Review
Medicine, General & Internal
Ying Dai, Yufei Zhang, Xue Ke, Yunqin Liu, Chunbao Zang
Summary: Cervical cancer metastases to the scalp are extremely rare, and may be the only symptomatic sign of disease progression or widespread metastatic lesions. There is no clear guideline for the treatment of skin metastases, so a comprehensive radiologic and pathologic workup is needed to develop a management plan.
JOURNAL OF MEDICAL CASE REPORTS
(2023)
Article
Oncology
Yunqin Liu, Chunbao Zang, Liting Qian, Ailin Wu, Xue Ke
Summary: The study demonstrated that dose-painted intensity-modulated radiotherapy combined with chemotherapy achieved good outcomes for stage IIIB cervical cancer patients, with a 5-year overall survival rate of 61.0% and progression-free survival rate of 55.0%. The cumulative rates of total grade 3 or higher chronic gastrointestinal or genitourinary toxicities were relatively low.
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
(2021)